IRLAB: Invitation to the Interim Report for Q1 2023 Presentation and Webcast
GOTHENBURG, SE / ACCESSWIRE / May 03, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, May 3, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's …
Weiterlesen »